spacer
home > pmps
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

 

Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision-makers within the industry, identifying new trends and marketing opportunities as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharmaceutical, biotech, nutritional and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.


 

For further information please contact:

Advertising
Garry Rubie

Nicholas Matthews

Editorial  
Angela Cottrell

We're also on Twitter! Follow us @PMPSmag  

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


Click here to view the digital version of PMPS

 

pmps
 
 
Featured in this issue
MANUFACTURING & PROCESSING
Compressed Air

Pure and Simple


Sometimes referred to as the fourth utility, compressed air plays a vital part in manufacturing operations. But it is vulnerable to contamination, and this can come from many different sources. David Whelan at IMI Precision Engineering offers his thoughts on today’s purification technologies.
Cool Chain, Cargo & Logistics
Roundtable: Cool Chain Integration

All Together Now


Cool chain logistics is a complex but crucial part of the pharma industry. At a roundtable discussion held last year by the Cool Chain Association – attended by a number of its board members and other interested parties – supply chain integration was the main talking point.
  MARKETPLACE & BUSINESS
Second-User Equipment

Every Penny Counts


Once the remit of cash-strapped start-ups, purchasing of second-user equipment is now on the rise – even among global, multi-facility pharma giants. EquipNet’s Ben Potenza shares his golden rules for companies considering this route.

spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development
Published quarterly in
February, May,
August and October
Banner of PDA_Universe of Prefilled Syringes_PMPS on Samedan
Banner of Samedan app.PMPS on Samedan
Banner of RDD Europe on Samedan
 
Industry Events

Managing Risk, Complexity and Compliance

10-12 June 2015, Warsaw, Poland

Clinical trial management continues to face challenges in achieving the timelines and quality standards needed to meet ever-increasing regulatory and commercial requirements. To help PCMG members prepare and overcome these challenges, its 2015 conference will focus on three topics: risk, complexity, and compliance in clinical outsourcing.
More info >>

 
News and Press Releases

Adents Demonstrates Commitment To North American Market With Two New Subsidiaries

Adents, the leading provider of robust and easily deployable software solutions for serialization in the life sciences industry, has announced the opening of its second subsidiary in the North American market.
More info >>

air transport logo

 

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement